ACAndreas Clemmensen

Andreas Clemmensen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Clemmensen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative evaluation of iodinated, nanoparticle-based, and gadolinium-based contrast agents in computed tomography for small animals

    by Julie van Krimpen Mortensen, Emil Svendborg Christensen, Amalie Littau, Nicoline Rosenkilde Kjaer, Sophie Arndt, Anne Skovsbo Clausen, Andreas Clemmensen, Andreas Kjaer

    Preclinical computed tomography (CT) is extensively used for anatomical reference and multimodal imaging, but the soft tissue contrast is poor compared to clinical CT. This hinders reliable organ delineation and segmentation in small-animal studies. We present a systematic evaluation of commonly used clinical iodinated and gadolinium-based contrast agents, together with a preclinical nanoparticle-based contrast agent. This evaluation aims to enhance soft-tissue boundary definition and in vivo visibility. The study consisted of two parts. First, phantom experiments were performed to assess the relationship between contrast-agent concentration and Hounsfield Unit (HU) across multiple dilutions and CT energy settings. Second, these findings were evaluated in vivo in mice to assess organ-level enhancement. Phantom measurements demonstrated a linear relationship between HU and concentration for all agents; however, at higher dilutions, contrast enhancement became indistinguishable from the background. In vivo, clinical iodinated and gadolinium-based agents administered intraperitoneal (IP) provided enhanced soft-tissue contrast by outlining abdominal organs, whereas the intravenously administered nanoparticle agent exhibited pronounced organ-specific accumulation. Overall, IP injection of clinical iodinated contrast agents offers a cost-effective and practical strategy for enhancing organ boundary visibility in preclinical CT. For longitudinal or organ-specific imaging studies, the preclinical nanoparticle-based contrast agent remains advantageous, as its cumulative uptake allows detection over extended periods and minimizes burden from multiple injections.

  • Open Access

    [68Ga]Ga-NODAGA-E[(cRGDyK)]2 Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction

    by Simon Bentsen, Andreas Clemmensen, Mathias Loft, Mette Flethøj, Karina Poulsdóttir Debes, Trine Pagh Ludvigsen, Cecilie Bjørstrup Larsen, Jeppe Kirchhoff, Lisbeth Høier Olsen, Jacob Eifer Møller, et al.

    Angiogenesis is crucial in tissue repair and prevents scar tissue formation following an ischemic event such as myocardial infarction. The ischemia induces formation of new capillaries, which have high expression of integrin αvβ3. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 ([68Ga]Ga-RGD) is a promising PET-radiotracer reflecting angiogenesis by binding to integrin αvβ3. A Göttingen mini-pig underwent transient catheter-induced left anterior descending artery (LAD) occlusion for 120 min, and after 8 weeks was imaged on a Siemens mMR 3T PET/MR system. A large antero-septal infarction was evident by late gadolinium enhancement (LGE) on the short axis and 2–4 chamber views. The infarcted area corresponded to the area with high [68Ga]Ga-RGD uptake on the fused PET/MR images, with no uptake in the healthy myocardium. To support the hypothesis that [68Ga]Ga-RGD uptake reflects angiogenesis, biopsies were sampled from the infarct border and healthy myocardium. Expression of αvβ3 was evaluated using immunohistochemistry. The staining showed higher αvβ3 expression in the capillaries of the infarct border compared to those in the healthy myocardium. These initial data confirm in vivo detection of angiogenesis using [68Ga]Ga-RGD PET in a translational model, which overall support the method applicability when evaluating novel cardio-protective therapies.


  • Open Access

    Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients

    by Adam E. Hansen, Henrik Gutte, Pernille Holst, Helle H. Johannesen, Sofie Rahbek, Andreas E. Clemmensen, Majbritt M.E. Larsen, Christina Schøier, Jan Ardenkjaer-Larsen, Thomas L. Klausen, et al.


  • Effects of menopause and high-intensity training on insulin sensitivity and muscle metabolism

    by Camilla M. Mandrup, Jon Egelund, Michael Nyberg, Lotte Hahn Enevoldsen, Andreas Kjær, Andreas E. Clemmensen, Anders Nymark Christensen, Charlotte Suetta, Ruth Frikke-Schmidt, Dorte Enggaard Steenberg, et al.

    Objective: To investigate peripheral insulin sensitivity and skeletal muscle glucose metabolism in premenopausal and postmenopausal women, and evaluate whether exercise training benefits are maintained after menopause. Methods: Sedentary, healthy, normal-weight, late premenopausal (n = 21), and early postmenopausal (n = 20) women were included in a 3-month high-intensity exercise training intervention. Body composition was assessed by magnetic resonance imaging and dual-energy x-ray absorptiometry, whole body glucose disposal rate (GDR) by hyperinsulinemic euglycemic clamp (40 mU/m2/min), and femoral muscle glucose uptake by positron emission tomography/computed tomography, using the glucose analog fluorodeoxyglucose, expressed as estimated metabolic rate (eMR). Insulin signaling was investigated in muscle biopsies. Results: Age difference between groups was 4.5 years, and no difference was observed in body composition. Training increased lean body mass (estimate [95% confidence interval] 0.5 [0.2-0.9] kg, P < 0.01) and thigh muscle mass (0.2 [−0.1 to 0.6] kg, P < 0.01), and decreased fat percentage (1.0 [0.5-1.5]%, P < 0.01) similarly in the two groups. The postmenopausal women had lower eMR in vastus lateralis muscle than the premenopausal women (−14.0 [−26.0 to −2.0] μmol/min/kg, P = 0.02), and tended to have lower eMR in femoral muscles (−11.2 [−22.7 to 0.4] μmol/min/kg, P = 0.06), and also GDR (−59.3 [−124.8 to 6.3] mg/min, P = 0.08), but increased similarly in both groups with training (eMR vastus lateralis muscle: 27.8 [19.6-36.0] μmol/min/kg, P < 0.01; eMR femoral muscle: 20.0 [13.1-26.7] μmol/min/kg, P < 0.01, respectively; GDR: 43.6 [10.4-76.9] mg/min, P = 0.01). Potential mechanisms underlying the training-induced increases in insulin sensitivity included increased expression of hexokinase (19.2 [5.0-24.7] AU, P = 0.02) and glycogen synthase (32.4 [15.0-49.8] AU, P < 0.01), and also increased insulin activation of Akt2 (20.6 [3.4-29.0], P = 0.03) and dephosphorylation of glycogen synthase (−41.8 [−82.9 to −0.7], P = 0.05). Conclusions: Insulin sensitivity was reduced in early postmenopausal women. However, postmenopausal women increased peripheral insulin sensitivity, skeletal muscle insulin-stimulated glucose uptake, and skeletal muscle mass to the same extent as premenopausal women after 3 months of high-intensity exercise training.